Search Within

Craig Moskowitz

  1. "Hematologic Malignancies Service"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (7)
Groups
  1. Center for Hematologic Malignancies (15)
  2. Department of Medicine (15)
  3. Hematologic Malignancies Service (15)
  4. Hematologic Malignancies, Division of (15)
  5. Pediatrics, Department of (15)
  6. Pediatric Leukemia (14)

More Groups

People
  1. Tanya Trippett (12)
  2. Andrew Zelenetz (9)
  3. Ariela Noy (8)
  4. Carol Portlock (8)
  5. David Straus (6)
  6. Joachim Yahalom (6)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2016 (1)
  4. 2015 (4)
  5. 2014 (1)
  6. 2011 (1)

More Years

Publications
  1. Blood (7)
  2. Leukemia and Lymphoma (2)
  3. Biology of Blood and Marrow Transplantation (1)
  4. Biomarker Research (1)
  5. British Journal of Haematology (1)
  6. European Journal of Cancer (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Elsevier Inc. (2)
  3. Taylor & Francis Group (2)
  4. Biomed Central Ltd (1)
  5. Elsevier Science, Inc. (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: The Memorial Sloan Kettering Cancer Center experience
    Journal Article

    Giulino-Roth, L.; O’Donohue, T.; Chen, Z.; Trippett, T. M.; Klein, E.; Kernan, N. A.; Kobos, R.; Prockop, S. E.; Scaradavou, A.; Shukla, N.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • A case report of concurrent embryonal rhabdomyosarcoma and diffuse large B-cell lymphoma in an adult without identifiable cancer predisposition
    Journal Article

    Mathias, M. D.; Ortiz, M. V.; Magnan, H.; Ambati, S. R.; Slotkin, E. K.; Chou, A. J.; Walsh, M. F.; Offit, K.; Moskowitz, C.; Kentsis, A.; more...
    Biomarker Research (2017)

    Fulltext@MSK | Save
  • PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Long-term follow up of pediatric patients with Hodgkin lymphoma treated with high dose therapy and autologous stem cell transplantation
    Meeting Abstract

    Roth, L. G.; O'Donohue, T.; Trippett, T.; Klein, E.; Kernan, N. A.; Kobos, R.; Prockop, S.; Scaradavou, A.; Shukla, N.; Steinherz, P. G.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas
    Journal Article

    Gounder, M.; Desai, V.; Kuk, D.; Agaram, N.; Arcila, M.; Durham, B.; Keohan, M. L.; Dickson, M. A.; D'Angelo, S. P.; Shukla, N.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma
    Journal Article

    Illidge, T.; Bouabdallah, R.; Chen, R.; Gopal, A. K.; Moskowitz, C. H.; Ramchandren, R.; Shustov, A. R.; Tilly, H.; Trippett, T. M.; Gibb, A.; more...
    Leukemia and Lymphoma (2015)

    Fulltext@MSK | Save
  • Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects
    Meeting Abstract

    Ganesh, K.; Batlevi, C.; Zhang, Z. G.; Hassoun, H.; Lendvai, N.; Landau, H.; Moskowitz, C. H.; Caron, P.; Motzer, R.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Allogeneic transplant following brentuximab vedotin treatment in patients with relapsed or refractory CD30+lymphomas
    Meeting Abstract

    Illidge, T.; Bouabdallah, R.; Chen, R. W.; Gopal, A. K.; Moskowitz, C. H.; Ramchandren, R.; Rosenblatt, J. D.; Shustov, A. R.; Tilly, H.; Trippett, T.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging: Research paper
    Journal Article

    Moskowitz, C. H.; Yahalom, J.; Zelenetz, A. D.; Zhang, Z.; Filippa, D.; Teruya-Feldstein, J.; Kewalramani, T.; Moskowitz, A. J.; Rice, R.; Maragulia, J.; more...
    British Journal of Haematology (2010)

    Fulltext@MSK | Save